Home Applications 218764 Application 218764
Type NDA
Sponsor BOEHRINGER INGELHEIM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 JASCAYD NERANDOMILAST TABLET;ORAL 9MG Yes No 002 JASCAYD NERANDOMILAST TABLET;ORAL 18MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218764-001 JASCAYD NERANDOMILAST 9MG TABLET / ORAL RLD 2025-10-07 N218764-002 JASCAYD NERANDOMILAST 18MG TABLET / ORAL RLD, RS 2025-10-07
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218764-001 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 N218764-001 8609670 2032-08-23 Drug substance 2025-10-29 N218764-001 9802954 2034-02-19 U-4298 2025-10-29 N218764-001 11406638 2038-10-22 U-4297 2025-10-29 N218764-001 11406638 2038-10-22 U-4373 2025-10-29 N218764-001 11813266 2038-10-22 U-4292 2025-10-29 N218764-001 11813266 2038-10-22 U-4372 2025-10-29 N218764-002 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 N218764-002 8609670 2032-08-23 Drug substance 2025-10-29 N218764-002 9802954 2034-02-19 U-4298 2025-10-29 N218764-002 11406638 2038-10-22 U-4297 2025-10-29 N218764-002 11406638 2038-10-22 U-4373 2025-10-29 N218764-002 11813266 2038-10-22 U-4292 2025-10-29 N218764-002 11813266 2038-10-22 U-4372 2025-10-29
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218764-001 JASCAYD 9MG TABLET / ORAL RLD 2025-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 JASCAYD 18MG TABLET / ORAL RLD, RS 2025-10-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 JASCAYD 9MG TABLET / ORAL RLD 2025-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 JASCAYD 18MG TABLET / ORAL RLD, RS 2025-10-07 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 JASCAYD 9MG TABLET / ORAL RLD 2025-10-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 JASCAYD 18MG TABLET / ORAL RLD, RS 2025-10-07 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218764-001 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 8609670 2032-08-23 Drug substance 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 9802954 2034-02-19 U-4298 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 11406638 2038-10-22 U-4373 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 11406638 2038-10-22 U-4297 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 11813266 2038-10-22 U-4372 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 11813266 2038-10-22 U-4292 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 8609670 2032-08-23 Drug substance 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 9802954 2034-02-19 U-4298 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 11406638 2038-10-22 U-4373 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 11406638 2038-10-22 U-4297 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 11813266 2038-10-22 U-4372 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 11813266 2038-10-22 U-4292 2025-10-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 8609670 2032-08-23 Drug substance 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 9802954 2034-02-19 U-4298 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 11406638 2038-10-22 U-4297 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 11813266 2038-10-22 U-4292 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 8609670 2032-08-23 Drug substance 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 9802954 2034-02-19 U-4298 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 11406638 2038-10-22 U-4297 2025-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 11813266 2038-10-22 U-4292 2025-10-29 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 8609670 2032-08-23 Drug substance 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 9802954 2034-02-19 U-4298 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 11406638 2038-10-22 U-4373 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 11406638 2038-10-22 U-4297 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 11813266 2038-10-22 U-4372 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 11813266 2038-10-22 U-4292 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 8754073 2029-11-26 U-4298 Drug substance, Drug product 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 8609670 2032-08-23 Drug substance 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 9802954 2034-02-19 U-4298 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 11406638 2038-10-22 U-4373 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 11406638 2038-10-22 U-4297 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 11813266 2038-10-22 U-4372 2025-10-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 11813266 2038-10-22 U-4292 2025-10-29 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218764-001 I-979 2028-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-001 NCE 2030-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 I-979 2028-12-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218764-002 NCE 2030-10-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-001 NCE 2030-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218764-002 NCE 2030-10-07 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 I-979 2028-12-19 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 NCE 2030-10-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-001 ODE-546 2032-10-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 I-979 2028-12-19 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 NCE 2030-10-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218764-002 ODE-546 2032-10-07 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join JASCAYD NERANDOMILAST Boehringer Ingelheim Pharmaceuticals, Inc. fa1b14c6-957f-d326-5099-911bfe33e391 2026-02-02 Adverse reactions Exact identifier application applno (NDA): 218764 application number: NDA218764
Documents# Document, Submission type, Date table Document Submission type Date 85196 SUPPL 2026-03-02 85195 SUPPL 2026-03-02 84099 ORIG 2025-11-06 83717 ORIG 2025-10-10 83688 ORIG 2025-10-07